
Julie Bichngoc Lieu
Examiner (ID: 11004, Phone: (571)272-2978 , Office: P/2684 )
| Most Active Art Unit | 2684 |
| Art Unit(s) | 2685, 2636, 2736, 2617, 2612, 2632, 2684, 2687 |
| Total Applications | 1900 |
| Issued Applications | 1489 |
| Pending Applications | 77 |
| Abandoned Applications | 341 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 817264
[patent_doc_number] => 07411072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Tricyclic steroid hormone nuclear receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/517010
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83519
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/411/07411072.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517010 | Tricyclic steroid hormone nuclear receptor modulators | Jun 12, 2003 | Issued |
Array
(
[id] => 390432
[patent_doc_number] => 07301028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Mitotic kinesin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/517576
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20676
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/301/07301028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517576 | Mitotic kinesin inhibitors | Jun 11, 2003 | Issued |
Array
(
[id] => 888596
[patent_doc_number] => 07348440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-25
[patent_title] => 'Mitotic kinesin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/517559
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/348/07348440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517559
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517559 | Mitotic kinesin inhibitors | Jun 11, 2003 | Issued |
Array
(
[id] => 7601629
[patent_doc_number] => 07385073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-10
[patent_title] => 'Method for reducing the content of an unsaturated amine in a mixture containing an amino nitrile, a diamine, a dinitrile or mixtures thereof'
[patent_app_type] => utility
[patent_app_number] => 10/515281
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4718
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/385/07385073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515281 | Method for reducing the content of an unsaturated amine in a mixture containing an amino nitrile, a diamine, a dinitrile or mixtures thereof | May 20, 2003 | Issued |
Array
(
[id] => 4567943
[patent_doc_number] => 07847095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one'
[patent_app_type] => utility
[patent_app_number] => 10/511691
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1594
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/847/07847095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511691
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511691 | Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one | Apr 16, 2003 | Issued |
Array
(
[id] => 5673014
[patent_doc_number] => 20060178369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Cinnamic acid amides'
[patent_app_type] => utility
[patent_app_number] => 10/512724
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178369.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512724 | Cinnamic acid amides | Apr 13, 2003 | Issued |
Array
(
[id] => 5851844
[patent_doc_number] => 20060235035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Novel methoxybenzamibe compounds for use in mch receptor related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/510907
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31621
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510907 | Novel methoxybenzamibe compounds for use in mch receptor related disorders | Apr 7, 2003 | Abandoned |
Array
(
[id] => 7020128
[patent_doc_number] => 20050222147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Process for the preparation of morpholine derivatives and intermediates therefore'
[patent_app_type] => utility
[patent_app_number] => 10/509519
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30724
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509519
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509519 | Process for the preparation of morpholine derivatives and intermediates therefore | Mar 26, 2003 | Abandoned |
Array
(
[id] => 5727538
[patent_doc_number] => 20060058299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 10/509417
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5875
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509417 | N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions | Mar 26, 2003 | Abandoned |
Array
(
[id] => 7105309
[patent_doc_number] => 20050107390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/508898
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19099
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508898 | β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | Mar 20, 2003 | Issued |
Array
(
[id] => 6939746
[patent_doc_number] => 20050113309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Crystalline forms(2s)-n-5[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2[(carboxymethyl) amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o'
[patent_app_type] => utility
[patent_app_number] => 10/508524
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4330
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508524 | Crystalline forms(2s)-n-5[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2[(carboxymethyl) amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o | Mar 20, 2003 | Abandoned |
Array
(
[id] => 303661
[patent_doc_number] => 07534800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => '7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 10/509128
[patent_app_country] => US
[patent_app_date] => 2003-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11963
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509128 | 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders | Mar 16, 2003 | Issued |
Array
(
[id] => 7074398
[patent_doc_number] => 20050147666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Tablets quickly disintegrating in oral cavity'
[patent_app_type] => utility
[patent_app_number] => 10/506349
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9800
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506349 | Tablets quickly disintegrating in oral cavity | Mar 5, 2003 | Abandoned |
Array
(
[id] => 6702394
[patent_doc_number] => 20030225274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Process for reducing 3-heteroaryl-3-oxopropionic acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/375344
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11264
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375344 | Process for reducing 3-heteroaryl-3-oxopropionic acid derivatives | Feb 26, 2003 | Issued |
Array
(
[id] => 903830
[patent_doc_number] => 07335782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Thioxanthone derivatives, and their use as cationic photoinitiators'
[patent_app_type] => utility
[patent_app_number] => 10/505615
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505615 | Thioxanthone derivatives, and their use as cationic photoinitiators | Feb 25, 2003 | Issued |
Array
(
[id] => 6990512
[patent_doc_number] => 20050089549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Feed for fish and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/504257
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6183
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504257 | Feed for fish and use thereof | Feb 19, 2003 | Abandoned |
Array
(
[id] => 5894452
[patent_doc_number] => 20060002991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/505107
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7319
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505107 | pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same | Feb 18, 2003 | Issued |
Array
(
[id] => 925809
[patent_doc_number] => 07317107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity'
[patent_app_type] => utility
[patent_app_number] => 10/503585
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7846
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/317/07317107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503585 | Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity | Feb 11, 2003 | Issued |
Array
(
[id] => 6983961
[patent_doc_number] => 20050154031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => '5-Ht2b receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/504538
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11369
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20050154031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504538 | 5-Ht2b receptor antagonists | Feb 10, 2003 | Abandoned |
Array
(
[id] => 7146612
[patent_doc_number] => 20050119489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => '4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor'
[patent_app_type] => utility
[patent_app_number] => 10/499789
[patent_app_country] => US
[patent_app_date] => 2002-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40611
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499789 | 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor | Dec 27, 2002 | Abandoned |